CareRx Corporation (29C1)
FSX
1.93
+0.03 (+1.58%)
Real-time Data
06:00 AM
Day's Range
1.931.93
52 wk Range
1.782.46
Financial Statements - 29C1 - CareRx Corporation
Revenue
370.24M▲ 1.0%
Net Income
26.12M▲ 680.5%Net Margin 7.1%
EBITDA
30.37M▲ 13.7%
Free Cash Flow
22.51M▼ 24.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 370.24M | 366.71M | 370.74M | 381.72M | 262.63M | 162.19M |
| Cost of Goods | 259.27M | 258.65M | 266.04M | 271.79M | 187.35M | 115.14M |
| Gross Profit | 110.96M | 108.06M | 104.69M | 109.93M | 75.27M | 47.05M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 11.88M | 7.45M | 7.22M | 7.63M | 4.81M | -1.20M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -1.84M | -2.80M | -3.80M | -28.58M | -13.95M | -14.14M |
| Pre Tax Income | 3.35M | -4.46M | -9.59M | -35.89M | -23.73M | -18.30M |
| Income Tax | -22.77M | 32K | -4.19M | -1.54M | -1M | -118K |
| Net Income | 26.12M | -4.50M | -5.40M | -34.35M | -22.73M | -18.26M |
| EPS Basic | 0.42 | -0.07 | -0.09 | -0.72 | -0.65 | -0.9 |
| EPS Diluted | 0.41 | -0.07 | -0.09 | -0.72 | -0.65 | -0.9 |
| Basic Shares Outstanding | 62.73M | 60.25M | 87.66M | 70.82M | 51.86M | 30.15M |
| Diluted Shares Outstanding | 62.73M | 60.25M | 87.66M | 70.82M | 51.86M | 30.15M |
| Ebit | 10.19M | 4.71M | 4.67M | -20.67M | -9.24M | -16.87M |
| Ebitda | 30.37M | 26.70M | 28.45M | 27.97M | 20.10M | 8.72M |
| Net Income Continuous Operations | 26.12M | -4.50M | -5.40M | -34.35M | -22.73M | -18.26M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
